Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of postpartum hemorrhage after cesarean section
ChiCTR1800015613Phase 4Recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Apr 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoint: Amount of postpartum hemorrhage. Started Apr 2018; status: recruiting.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ChiCTR1800015613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015613.